Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Terminated 2Active not recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 10163Neoplasms 7801Carcinoma, Non-Small-Cell Lung 5744Prostatic Neoplasms 5016Colorectal Neoplasms 4588Lung Neoplasms 3716Leukemia, Myeloid, Acute 3097Neoplasm Metastasis 3074Multiple Myeloma 3073Pancreatic Neoplasms 2837Melanoma 2646Lymphoma 2569Ovarian Neoplasms 2565Carcinoma, Hepatocellular 2473Stomach Neoplasms 2325Recurrence 2221Head and Neck Neoplasms 2095Precursor Cell Lymphoblastic Leukemia-Lymphoma 2084Lymphoma, Non-Hodgkin 2055Leukemia 2011Brain Neoplasms 1899Glioblastoma 1791Colonic Neoplasms 1790Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1714Uterine Cervical Neoplasms 1684Lymphoma, Follicular 1651Squamous Cell Carcinoma of Head and Neck 1649Lymphoma, Large B-Cell, Diffuse 1596Carcinoma, Renal Cell 1574

Interventions

Fulvestrant 2vistusertib 1proto-oncogene protein c-fes-fps 1capivasertib 1Transurethral Resection of Bladder 1Hydroxychloroquine 1Everolimus 1Estrogens 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Estrogen Receptor Positive Breast Cancer × Clear all
NCT01992952 2025-11-26

FAKTION

Velindre NHS Trust

Phase 1/2 Active not recruiting
149 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT06629233 2025-08-29

Tn-Miner

University Ghent

Phase NA Enrolling by invitation
36 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting
19 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02216786 2024-12-02

MANTA

Queen Mary University of London

Phase 2 Completed
333 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT04727632 2024-10-28

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02414776 2017-09-27

ABC01

Western Regional Medical Center

Phase 1 Terminated
3 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡